Rachel was part of the team involved in the management buyout of Armstrong Craven in 2013 and currently sits on the main board, responsible for business development and driving the sales performance of the business globally.
She advises global organizations on all aspects of talent management and helps them meet their strategic workforce requirements. She has a particular focus on diversity & inclusion, and organizational design and has built close relationships with multiple Fortune 50 and FTSE 100 organizations.
She joined Armstrong Craven in 1998 and held previous roles as COO and as the lead responsible for driving the global growth of the Healthcare and Life Sciences division. She holds a Masters in Chemistry and French from the University of Manchester, England.